Which hedge funds own NSRX? NASUS PHARMA LTD, Q2 2026 13F holders
5 of the hedge funds tracked by WhaleCreep disclosed a position in NSRX (NASUS PHARMA LTD) in their Q2 2026 13F filings, worth $6.2m in total. The largest holder by portfolio weight is Bleichroeder LP at 0.1% of its book. 1 manager opened a new position this quarter: Citadel Advisors LLC. 1 exited: Empery Asset Management, LP.
5tracked managers holding
1opened this quarter
1exited this quarter
Which hedge funds hold NSRX? Current holders by portfolio weight
| Manager | As of | Weight of book | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|
| Bleichroeder LP | Q2 2026 | 0.1% | $314.5k | 89,848 | 0% | held |
| Cable Car Capital, LP | Q2 2026 | 0.0% | $2.2m | 616,081 | 2% | added |
| Balyasny Asset Management L.P. | Q2 2026 | 0.0% | $3.1m | 898,473 | 0% | held |
| Hudson Bay Capital Management LP | Q2 2026 | 0.0% | $471.7k | 134,771 | 0% | held |
| Citadel Advisors LLC | Q2 2026 | 0.0% | $77.0k | 22,004 | – | new |
Exited since the previous quarter
| Manager | Prior weight | Prior value |
|---|---|---|
| Empery Asset Management, LP | 1.0% | $101.7k |
Held in a manager's last filing on record
These managers have not filed for the latest quarter; their last disclosure is dated.
| Manager | Last filing | Weight |
|---|---|---|
| renaissance | Q2 2026 | 0.0% |
How has hedge fund ownership of NSRX changed?
| Quarter | Managers holding | Combined value |
|---|---|---|
| Q2 2026 | 6 | $6.2m |
| Q1 2026 | 5 | $3.9m |
Counts every tracked manager that disclosed NSRX in that quarter's filing, including managers that have since stopped filing.